Didn't add pathways!!!!!!!!!!!!!!!!!!!!!!!!!!!
Complement
series of 50+ soluble and cell-bound proteins that interact to enhance host defense mechanisms against foreign cells
Most plasma complement proteins are synthesized in the
liver (except C1 + Factor D)
Monocytes/macrophages are additional sources of complements…
C1, C2, C3, C4
Most complements are
zymogens (inactive precursor) that are converted to active enzymes
Complement synthesis increases in
acute inflammation
Complements are decreased in
chronic inflammation or liver disease
Functions of Complement Components
host defense against infection (cause of lysis)
Inflammation (opsonization, increase vascular permeability)
Clears immune complexes
Complements are the link between innate and acquired immunity because
C3b, C4b etc have roles in activation B cells + antigen presenting cells
Trigger secretion of immunoregulatory molecules that amplify the immune response
Enhancing memory through interactions with B cells and follicular dendritic cells
Complement activation
C proteins alteration such that they interact with next component
Complement fixation
utilization of complement by ag-ab complexes
Complement inactivation
early C component denaturation resulting in cell lytic activity loss
Convertase/esterase
altered C proteins which acts as proteolytic enzyme for another C component
Stages of the Classical Pathway
C1 - C9
Reconition: C binds to antigen-antibody complex
Activation: Ca fragments are created & combine to form active enzymes
Membrane attack: attaching complex is formed → cell lysis
Substances that initiate the Classical Pathway
Antibodies (IgG + IgM mainly)
C-reactive protein
mycoplasmas
gram (-) bacteria
Complement Activation
piece that “floats away” & has biological activities in solution “a” component
execption: C2 → Cb component floats away
The Lectin Pathway is activated by
carbohydrates on microbial cell walls
Lectin Pathway involves 3 classes of recognition molecules
lectins, ficolins, CL-L1
Mannan-binding lectin (MBL)
acute-phase protein
Binds to mannose or related sugars on microbes to initiate pathway
Alternative pathway acts mainly as an…
amplification loop for classical or lectin pathways
Alt. Pathway involves
C3, C5-C9, Factors B,D, and P
Alt. Pathway can be activated by
LPS
fungal/yeast/virus
virally infected cells
Tumor cells
some parasites
Complement System regulators
plasma proteins (doesn’t harm self/localized rxns)
Certain cell receptors
C3 step to halt accumulation of C3b
C1 inhibitor (C1INH) inactives C1 and its removal causes….
C1r and C1s to dissociate from C1q
CR1 (complement receptor type 1) (CD35) Classical Pathway Regulator
on peripheral blood cell surface
binds to C3b, C4b, then degraded by factor 1
CR1 on RBC bind to C3b coated immune complex & brings it to liver/spleen
Immune adherence
the ability of cells to bind complement-coated particles
DAF (Decay accelerating factor) CD55 Classical Pathway Regulator
Dissociation of C2 → Bb binding (halts formation of classical/alt. C3 convertases)
Used for indenfitication of self vs. non self
Factor H Alt. Pathway Regulator
binds to C3b which binds to Factor I
Factor I breaks down C3b to C3dg
C1INH also inhibits the lectin pathway by
inhibiting binding of MBL-MASP-2
S Protein
prevents attachment of C5b67 complex to cell membrane
Prevents bystander cell damage by membrane active components
CD59
blocks C9 insertion (on all blood, endothelial, and epithelial cells)
Complement fragment (a)
amplifies inflammatory response
facilitates B-cell activation
Anaphylatoxins
C5a, C4a, C2a
Chemotaxins
C5a
Opsonins
C3b, C4b, iC3b, C3dg, C1q
C3 deficiency affects all pathways, leading to
decrease phagocytosis, immune complex clearance, class switching
seseptible to recurrent bacterial infections
C5-C9 terminal compoent deficiency leads to
SLE (lupus)
unable to penetrate outer membrane of G(-) bacteria
C1, C4, and C2 deficiencies increase risk of
autoimmune connective tissue diseases
recurrent infections
Lectin pathway deficiencies
associated with bacterial infections with infants
Alt. pathway deficiencies
pyogenic bacteria
not able to opsonize bacteria
affects properdin, factors H, I, B, or D, MASP-2
Paroxysmal Nocturnal Hemoglobinuria (PNH)
deficiencies of DAF and CD59
chronic hemolytic anemia
Hereditary angioedema (HAE)
C1 inhibitor deficiency
Increase in C1s activities
Swelling
Atypical hemolytic uremic syndrome (aHUS)
kacute renal failure in children
mutations in factor H, I, B. MCP, C3, thrombomodulin, or autoantibodies against factor H
C3 glomerulopathy
inflammation of the renal glomeruli that may be due to autoantibodies that cause C dysregulation
Antigenic assays
measure amount of each component (protein) in serum but does not distinguish if functionally active
Functional assays
measure functinoal activity of components or pathways
CH50 Assay
dilution that 50% antigen coated cells lysed
AH50
measure function initiated through alternative pathway
measurement of complement activation products (C5a/C5b-9)
CH50 and AH50 require complement components
C3 and C5-9
CH50 needs
C1, C2, C4, C1INH
AH50 needs
Factor B, Factor D, Properdin and Factor H + I
High complement levels indicate
acute inflammation
Low complement levels indicate
genetic deficiencies
Chronic infection
incorrectly processed serum samples